Role of Lymphocytic Choriomeningitis Virus (LCMV) in Understanding Viral Immunology: Past, Present and Future

by Xin Zhou, Srividya Ramachandran, Margaret Mann, Daniel L. Popkin
Published 2012-10-01

In vitro Evidence That Combination Therapy With CD16-Bearing NK-92 Cells and FDA-Approved Alefacept Can Selectively Target the Latent HIV Reservoir in CD4+ CD2hi Memory T Cells

by Amanda G. Tomalka, Ivelisse Resto-Garay, Kerry S. Campbell, Daniel L. Popkin
Published 2018-11-01

Slc15a4, a gene required for pDC sensing of TLR ligands, is required to control persistent viral infection.

by Amanda L Blasius, Philippe Krebs, Brian M Sullivan, Michael B Oldstone, Daniel L Popkin
Published 2012-09-01

Cetylpyridinium Chloride (CPC) Exhibits Potent, Rapid Activity Against Influenza Viruses in vitro and in vivo

by Daniel L. Popkin, Sarah Zilka, Matthew Dimaano, Hisashi Fujioka, Cristina Rackley, Robert Salata, Alexis Griffith, Pranab K. Mukherjee, Mahmoud A. Ghannoum, Frank Esper
Published 2017-06-01

Soluble Markers of Immune Activation Differentially Normalize and Selectively Associate with Improvement in AST, ALT, Albumin, and Transient Elastography During IFN-Free HCV Therap...

by Lenche Kostadinova, Carey L. Shive, Elizabeth Zebrowski, Brianna Fuller, Kelsey Rife, Amy Hirsch, Anita Compan, Anita Moreland, Yngve Falck-Ytter, Daniel L. Popkin, Donald D. Anthony
Published 2018-09-01